Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator

Annals of Allergy, Asthma and Immunology

Volumn 86, Issue 4, 2001, Pages 397-404

  O'Connor, Brian ^a,g   Bonnaud, Gérard ^b   Haahtela, Tari ^c   Luna, Juan M ^d   Querfurt, Herbert ^e   Wegener, Thomas ^f   Lutsky, Barry N ^g  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Clinique de Coancy   (France)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Hosp Nuestra Senora del Pilar   (Guatemala)

^e Department of Pulmonary Medicine ^*  (Germany)

^f Schering Plough Research Institute ^*  (Sweden)

^g MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; MOMETASONE FUROATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035055358     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62485-4     Document Type: Article

References (24)

1. Global initiative for asthma
2. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
3. Efficacy and safety of inhaled corticosteroids: New developments
4. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics
5. Adverse effects of inhaled corticosteroids
6. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network
7. Development of fluticasone propionate and comparison with other inhaled corticosteroids
8. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids
9. Cytokine inhibition by a novel steroid, mometasone furoate
10. + T cells
11. Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines
12. Glucocorticosteroids inhibit leukotriene production
13. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients
14. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray
15. Comparison of mometasone furoate dry powder inhaler (MF-DPI) with Pulmicort Turbuhaler using a new methodology for in vitro analysis of inhaler performance
16. Analysis of particle size distribution with the new mometasone furoate dry powder inhaler (MF-DPI)
17. Assessment of dose uniformity with the new mometasone furoate dry powder inhaler (MF-DPI)
18. Dose-ranging study of a new steroid for asthma: Mometasone furoate dry powder inhaler
19. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
20. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
21. Dose-related effect of beclomethasone dipropionate on airway responsiveness in asthma
22. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma
23. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma